0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.211.190.232. Please contact the publisher to request reinstatement.
Small Case Series |

Lagophthalmos in Severe Anorexia Nervosa: A Case Series FREE

Jennifer L. Gaudiani, MD; Jon M. Braverman, MD; Margherita Mascolo, MD; Philip S. Mehler, MD, CEDS, FAED
[+] Author Affiliations

Author Affiliations: Department of Internal Medicine, Denver Health Medical Center, University of Colorado School of Medicine (Drs Gaudiani, Mascolo, and Mehler) and Division of Ophthalmology, ACUTE Center for Eating Disorders at Denver Health (Dr Braverman), Colorado.


Arch Ophthalmol. 2012;130(7):928-930. doi:10.1001/archophthalmol.2011.2515.
Text Size: A A A
Published online

Anorexia nervosa is characterized in the Diagnostic and Statistical Manual of Mental Disorders (Fourth Edition) by (1) a refusal to maintain a minimally normal body weight (eg, a body weight of <85% of expected body weight or a body mass index [BMI; calculated as weight in kilograms divided by height in meters squared] of <17.5), (2) an intense fear of gaining weight, (3) a disturbance in the evaluation of one's own body shape, and (4) amenorrhea.1 Anorexia nervosa has the highest mortality of any psychiatric illness and has a lifetime estimated prevalence of 0.9% in women and 0.3% in men, with a standardized mortality ratio of 45 for patients whose lifetime nadir BMI is less than 10.5.2,3 A subset of patients with anorexia nervosa develop such severe disease that they require medical hospitalization for stabilization before they are able to be admitted to traditional eating disorder programs. The ACUTE Center for Eating Disorders at Denver Health in Colorado is an inpatient unit with multidisciplinary expertise in caring for such critically ill patients.

We describe 5 patients with severe anorexia nervosa who were admitted to the ACUTE Center and who complained of dry, irritated eyes and photophobia. Examination revealed lagophthalmos in the setting of enophthalmos and pseudoptosis with a narrowed palpebral fissure, with multiple other starvation-mediated medical complications. Protective measures, including the use of sterile topical ophthalmic ointment and taping shut the eyelids every night, with the use of topical lubrication during the day, in addition to volume repletion and modest weight restoration, resolved both the lagophthalmos and the secondary ocular exposure symptoms. We will describe 1 case in detail and make mention of the other 4 cases.

Case 1

A 26-year-old woman with anorexia nervosa was admitted to our institution with a height of 1.524 m (5 ft), a weight of 25.5 kg (56.7 lb), a BMI of 10.9, and a percentage of ideal body weight of 56%. In her first week of hospitalization, her medical complications included volume depletion, bradycardia, hypoglycemia in the single digits, hyponatremia, pancytopenia, starvation hepatitis, dysphagia causing aspiration, patulous eustachian tubes with autophonia, and refeeding hypophosphatemia. On the day of admission, she also complained of dry, irritated eyes with photophobia, and an initial examination showed pseudoptosis and enophthalmos, which were not formally measured, and 1-mm lagophthalmos. Topical lubrication was prescribed, with several drops of artificial tears in each eye hourly during the day and a ribbon of sterile ophthalmic ointment followed by direct taping of the eyelids during the night. The patient's weight reached its nadir on hospital day 5, at 23.8 kg (52.8 lb), and on hospital day 11, without any improvement in her symptoms, she was evaluated by an ophthalmologist. Examination confirmed enophthalmos bilaterally and 1-mm lagophthalmos, and corneal inspection revealed mild bilateral punctate epithelial erosions without frank defects or ulceration. Continued topical protection with nightly taping was recommended, and on hospital day 24, the patient's symptoms had resolved completely, with a weight increase from nadir of 4.5 kg (10 lb; Tables 1 and 2).

Table Graphic Jump LocationTable 1. Characteristics of 5 Patients With Severe Anorexia Nervosa
Table Graphic Jump LocationTable 2. Course of Lagophthalmos for Patients With Severe Anorexia Nervosa
Remaining Cases

In the remaining 4 cases, each young woman with multiorgan dysfunction related to severe anorexia nervosa noted eye discomfort shortly after admission, and examination by the attending internist confirmed pseudoptosis, enophthalmos, and lagophthalmos. Patients' symptomatic responses to topical protective measures were rapid and were associated with resolution of the lagophthalmos, and thus no ophthalmology consultation was requested in these cases.

Case 2

A 27-year-old woman with anorexia nervosa was admitted to our institution with a height of 1.727 m (5 ft, 8 in) and a weight of 29.9 kg (65.8 lb), giving her a BMI of 10 and a percentage of ideal body weight of 47%. On hospital day 6, her eye symptoms developed and persisted for 10 days after topical treatment was initiated, until the patient had gained 1 kg from her nadir weight.

Case 3

A 24-year-old woman with anorexia nervosa was admitted to our institution with a height of 1.676 m (5 ft, 6 in) and a weight of 26.9 kg (59.2 lb), giving her a BMI of 9.5 and a percentage of ideal body weight of 46%. On the day of admission, she noted eye symptoms that resolved after 11 days of topical treatment. At the time of resolution, her weight had increased from its nadir by 1.3 kg.

Case 4

A 34-year-old woman with anorexia nervosa was admitted to our institution with a height of 1.524 m (5 ft), a weight of 23.8 kg (52 lb), a BMI of 10.2, and a percentage of ideal body weight of 52%. On the day of admission, she noted eye symptoms that resolved 4 days after topical treatments were instituted, at which point her weight had increased by 3.1 kg, much of which was related to improvement in volume status.

Case 5

A 21-year-old woman with anorexia nervosa was admitted to our institution with a height of 1.651 m (5 ft, 5 in), a weight of 31.2 kg (68.6 lb), a BMI of 11.4, and a percentage of ideal body weight of 55%. On hospital day 2, she described dry, irritated eyes. By hospital day 12, with a weight increase of 3.8 kg and attention to protective topical treatments, her symptoms had resolved.

To our knowledge, no description of lagophthalmos in anorexia nervosa exists in the literature. In the aforementioned case series, we present 5 patients with severe anorexia nervosa, all admitted from out of state to a highly specialized medical stabilization center, whose mean (SD) BMI of 10.4 (0.8) at admission placed them at a very high mortality risk. Given their lagophthalmos and secondary ocular exposure, each was at risk for corneal complications. The onset of ocular symptoms occurred between hospital days 1 and 4 and resolved within a median of 11 days.

Ocular surface drying is a multifactorial issue. Lagophthalmos is commonly caused by facial nerve paralysis (cranial nerve VII). The differential diagnosis of such paralysis includes infection, trauma, malignancy, and iatrogenic postoperative causes.4 Other causes of lagophthalmos are related to cicatricial changes of the eyelids due to chemical/thermal injury or disorders like Stevens-Johnson syndrome, and neurogenic lid retraction and/or exophthalmos as seen in thyroid-related orbit disease.5

In this case series, we postulate that severe starvation, resulting in orbital fat atrophy, is the primary cause of the mechanical/anatomic abnormality between the globes and eyelids that leads to clinical lagophthalmos and ocular surface drying. Such a mechanism has also been noted in elderly patients with enophthalmos,6 with one case report of a patient with human immunodeficiency virus–associated lipoatrophy, whose radiologically proven orbital fat atrophy caused bilateral enophthalmos.7

All but one of the patients were profoundly volume depleted on admission, and slow reversal of this state likely contributed substantially to their improvement. Indeed, the patients' mean (SD) increase in weight from nadir to symptom resolution of 2.9 (1.8) kg reflects an increase more in their volume status than in their actual body weight. However, we have treated many volume-depleted patients with similarly low body weights who have not manifested lagophthalmos, so there may be other contributing variables. The limitations of this case series include the fact that only 1 of the 5 patients had a formal examination by an ophthalmologist and that formal measurements of enophthalmos were not performed.

In summary, these 5 patients had complications of virtually every organ system as a result of their severe anorexia nervosa, including their ocular system. However, in a relatively short amount of time, with careful protective measures, volume repletion, and initiation of nutritional rehabilitation, these patients' ocular abnormalities and associated symptoms resolved completely. We recommend the use of preservative-free eye drops in the setting of hourly use, to reduce the incidence of preservative-mediated eye irritation. Recognition of this pathology, early intervention with strong encouragement to enter expert care, and appropriate management can prevent long-term morbidity and improve outcomes for these types of patients with severe anorexia nervosa.

Correspondence: Dr Gaudiani, MD, Department of Internal Medicine, Denver Health Medical Center, University of Colorado School of Medicine, 777 Bannock St, MC 4000, Denver, CO 80204 (jennifer.gaudiani@dhha.org).

Author Contributions: Dr Gaudiani had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.

Financial Disclosure: None reported.

Additional Information: Institutional review board approval is not required for a case series of this nature at our institution.

American Psychiatric Association.  Diagnostic and Statistical Manual of Mental Disorders (Fourth Edition): DSM-IV. Washington, DC: American Psychiatric Association; 1994
Hudson JI, Hiripi E, Pope HG Jr, Kessler RC. The prevalence and correlates of eating disorders in the National Comorbidity Survey Replication.  Biol Psychiatry. 2007;61(3):348-358
PubMed   |  Link to Article
Rosling AM, Sparén P, Norring C, von Knorring AL. Mortality of eating disorders: a follow-up study of treatment in a specialist unit 1974-2000.  Int J Eat Disord. 2011;44(4):304-310
PubMed   |  Link to Article
Pereira MV, Glória AL. Lagophthalmos.  Semin Ophthalmol. 2010;25(3):72-78
PubMed   |  Link to Article
Kuriyan AE, Phipps RP, Feldon SE. The eye and thyroid disease.  Curr Opin Ophthalmol. 2008;19(6):499-506
PubMed   |  Link to Article
Yip CC, Gonzalez-Candial M, Jain A, Goldberg RA, McCann JD. Lagophthalmos in enophthalmic eyes.  Br J Ophthalmol. 2005;89(6):676-678
PubMed   |  Link to Article
Merchante N, García-García JA, Vergara S, Mira JA, Macías J, Pineda JA. Bilateral enophthalmos as a manifestation of HIV infection-related lipoatrophy.  HIV Med. 2004;5(6):448-449
PubMed   |  Link to Article

Figures

Tables

Table Graphic Jump LocationTable 1. Characteristics of 5 Patients With Severe Anorexia Nervosa
Table Graphic Jump LocationTable 2. Course of Lagophthalmos for Patients With Severe Anorexia Nervosa

References

American Psychiatric Association.  Diagnostic and Statistical Manual of Mental Disorders (Fourth Edition): DSM-IV. Washington, DC: American Psychiatric Association; 1994
Hudson JI, Hiripi E, Pope HG Jr, Kessler RC. The prevalence and correlates of eating disorders in the National Comorbidity Survey Replication.  Biol Psychiatry. 2007;61(3):348-358
PubMed   |  Link to Article
Rosling AM, Sparén P, Norring C, von Knorring AL. Mortality of eating disorders: a follow-up study of treatment in a specialist unit 1974-2000.  Int J Eat Disord. 2011;44(4):304-310
PubMed   |  Link to Article
Pereira MV, Glória AL. Lagophthalmos.  Semin Ophthalmol. 2010;25(3):72-78
PubMed   |  Link to Article
Kuriyan AE, Phipps RP, Feldon SE. The eye and thyroid disease.  Curr Opin Ophthalmol. 2008;19(6):499-506
PubMed   |  Link to Article
Yip CC, Gonzalez-Candial M, Jain A, Goldberg RA, McCann JD. Lagophthalmos in enophthalmic eyes.  Br J Ophthalmol. 2005;89(6):676-678
PubMed   |  Link to Article
Merchante N, García-García JA, Vergara S, Mira JA, Macías J, Pineda JA. Bilateral enophthalmos as a manifestation of HIV infection-related lipoatrophy.  HIV Med. 2004;5(6):448-449
PubMed   |  Link to Article

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics